News

Digital Biomarkers Market Revenue to be Worth USD 19,388.35 Million By 2028

Global Digital Biomarkers Market Size Was Valued at USD 1808.30 Million In 2021, And Is Projected to Reach USD 19,388.35 Million By 2028, Growing at A CAGR of 40.34% From 2022 To 2028.

Spread the love

 Digital biomarkers are physiological and behavioral data that are gathered and assessed using digital devices such as portables, wearables, implantable, or digestible. Typically, the information gathered is utilized to explain, affect, and/or forecast health-related outcomes. The growing use of digital biomarkers in therapeutic areas such as cardiovascular illness, sleep, and movement disorders, neurodegenerative diseases, mental disorders, gastrointestinal disease, respiratory disease, and diabetes is driving the market for digital biomarkers.

Digital biomarkers are physiological and behavioral data that are gathered and assessed using digital devices such as portables, wearables, implantable, or digestible. Typically, the information gathered is utilized to explain, affect, and/or forecast health-related outcomes. The growing use of digital biomarkers in therapeutic areas such as cardiovascular illness, sleep, and movement disorders, neurodegenerative diseases, mental disorders, gastrointestinal disease, respiratory disease, and diabetes is driving the market for digital biomarkers.

Download a Free Sample Copy of the Market Report:- 

https://www.introspectivemarketresearch.com/request/16260

The Major Players In The Digital Biomarkers Market Include:

  • AliveCor Inc.
  • Bayer AG
  • Evidation Health Inc.
  • Fitbit Inc.
  • Happify Health
  • Koninklijke Philips NV
  • Neurotrack Technologies Inc.
  • GlaxoSmithKline Inc.
  • Novartis International AG
  • F. Hoffmann-La Roche Ltd.

Market has segmented the global Digital Biomarkers market on the basis of type, application, and region:

By Type:

  • Data Collection Tools
  • Data Integration Systems

If You Have Any Query of Digital Biomarkers Market Report, Visit.@

https://www.introspectivemarketresearch.com/inquiry/16260

 By Application:

  • Biopharmaceutical
  • Providers
  • Payers

By Regional Outlook (Revenue, USD Billion, 2017 – 2028)

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)

Get Discount on This Report @: 

https://www.introspectivemarketresearch.com/discount/16260

Covid-19 Impact and Recovery Analysis on Industry:

COVID-19 protocols ranging from declaring national emergency states, enforcing stay-at-home orders, closing nonessential business operations and schools, banning public gatherings, imposing curfews, distributing digital passes, and allowing police to restrict citizen movements within a country, as well as closing international borders. With the growing vaccination rate, governments are uplifting the protocols to give a boost to the stagnant economy. Like other industries, Digital Biomarkers Market have experienced slowdown the growth, however market is expected bounce back as restrictions are being lifted up by governments across the globe.

Report covered the major key points:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 7years, along with 5 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key Industry Developments In Digital Biomarkers Market

October 2020, Medidata, a company that specializes in clinical trial data and life science technologies, has announced the acquisition of MC10’s digital biomarker business. The purchase is intended to improve the integration of clinical-grade measurements into the remote trial platform and bolster the use of wearable sensors in clinical research.

In September 2020, Koneksa, a company that develops and implements patient-specific digital biomarkers for use in the drug development process, has announced the completion of a USD 16.0 million Series B investment round. By extending its digital platform, Koneska plans to use the funds to integrate wearables and other patient-specific technology into clinical research.

Purchase Report: –

https://introspectivemarketresearch.com/checkout/?user=1&_sid=16260

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

Email : sales@introspectivemarketresearch.com


Spread the love

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button